AAAAAA

   
Results: 1-14 |
Results: 14
GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS ISOLATED FROM AIDS PATIENTS AFTER PROLONGED ADEFOVIR DIPIVOXIL THERAPY
Authors: MULATO AS LAMY PD MILLER MD LI WX ANTON KE HELLMANN NS CHERRINGTON JM
Citation: As. Mulato et al., GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS ISOLATED FROM AIDS PATIENTS AFTER PROLONGED ADEFOVIR DIPIVOXIL THERAPY, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1620-1628
A POINT MUTATION IN THE HUMAN CYTOMEGALOVIRUS DNA-POLYMERASE GENE SELECTED IN-VITRO BY CIDOFOVIR CONFERS A SLOW REPLICATION PHENOTYPE IN CELL-CULTURE
Authors: CIHLAR T FULLER MD MULATO AS CHERRINGTON JM
Citation: T. Cihlar et al., A POINT MUTATION IN THE HUMAN CYTOMEGALOVIRUS DNA-POLYMERASE GENE SELECTED IN-VITRO BY CIDOFOVIR CONFERS A SLOW REPLICATION PHENOTYPE IN CELL-CULTURE, Virology (New York, N.Y. Print), 248(2), 1998, pp. 382-393
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE EXPRESSING THE K70E MUTATION EXHIBITS A DECREASE IN SPECIFIC ACTIVITY AND PROCESSIVITY
Authors: MILLER MD LAMY PD FULLER MD MULATO AS MARGOT NA CIHLAR T CHERRINGTON JM
Citation: Md. Miller et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE EXPRESSING THE K70E MUTATION EXHIBITS A DECREASE IN SPECIFIC ACTIVITY AND PROCESSIVITY, Molecular pharmacology, 54(2), 1998, pp. 291-297
ANTI-HIV ACTIVITY OF ADEFOVIR (PMEA) AND PMPA IN COMBINATION WITH ANTIRETROVIRAL COMPOUNDS - IN-VITRO ANALYSES
Authors: MULATO AS CHERRINGTON JM
Citation: As. Mulato et Jm. Cherrington, ANTI-HIV ACTIVITY OF ADEFOVIR (PMEA) AND PMPA IN COMBINATION WITH ANTIRETROVIRAL COMPOUNDS - IN-VITRO ANALYSES, Antiviral research, 36(2), 1997, pp. 91-97
IN-VITRO CHARACTERIZATION OF THE ANTI-HUMAN CYTOMEGALOVIRUS ACTIVITY OF PMEA (ADEFOVIR)
Authors: XIONG XF FLORES C FULLER MD MENDEL DB MULATO AS MOON K CHEN MS CHERRINGTON JM
Citation: Xf. Xiong et al., IN-VITRO CHARACTERIZATION OF THE ANTI-HUMAN CYTOMEGALOVIRUS ACTIVITY OF PMEA (ADEFOVIR), Antiviral research, 36(2), 1997, pp. 131-137
THE SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL, A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: DEEKS SG COLLIER A LALEZARI J PAVIA A RODRIGUE D DREW WL TOOLE J JAFFE HS MULATO AS LAMY PD LI WX CHERRINGTON JM HELLMANN N KAHN J
Citation: Sg. Deeks et al., THE SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL, A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, The Journal of infectious diseases, 176(6), 1997, pp. 1517-1523
ANTI-HCMV ACTIVITY OF CIDOFOVIR IN COMBINATION WITH ANTIVIRAL COMPOUNDS AND IMMUNOSUPPRESSIVE AGENTS - IN-VITRO ANALYSES
Authors: MULATO AS CHERRINGTON JM CHEN MS
Citation: As. Mulato et al., ANTI-HCMV ACTIVITY OF CIDOFOVIR IN COMBINATION WITH ANTIVIRAL COMPOUNDS AND IMMUNOSUPPRESSIVE AGENTS - IN-VITRO ANALYSES, Antiviral chemistry & chemotherapy, 7(4), 1996, pp. 203-208
INHIBITION OF HIV-1 RNASE-H ACTIVITY BY NUCLEOTIDE DIMERS AND MONOMERS
Authors: ALLEN SJW KRAWCZYK SH MCGEE LR BISCHOFBERGER N MULATO AS CHERRINGTON JM
Citation: Sjw. Allen et al., INHIBITION OF HIV-1 RNASE-H ACTIVITY BY NUCLEOTIDE DIMERS AND MONOMERS, Antiviral chemistry & chemotherapy, 7(1), 1996, pp. 37-45
EVALUATION OF ADEFOVIR (PMEA) AND PMPA IN COMBINATION WITH REVERSE-TRANSCRIPTASE AND PROTEASE INHIBITORS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN-VITRO
Authors: CHERRINGTON JM MULATO AS CHEN MS
Citation: Jm. Cherrington et al., EVALUATION OF ADEFOVIR (PMEA) AND PMPA IN COMBINATION WITH REVERSE-TRANSCRIPTASE AND PROTEASE INHIBITORS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN-VITRO, AIDS, 10, 1996, pp. 108-108
NOVEL MUTATION (K70E) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONFERS DECREASED SUSCEPTIBILITY TO 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE IN-VITRO
Authors: CHERRINGTON JM MULATO AS FULLER MD CHEN MS
Citation: Jm. Cherrington et al., NOVEL MUTATION (K70E) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONFERS DECREASED SUSCEPTIBILITY TO 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE IN-VITRO, Antimicrobial agents and chemotherapy, 40(9), 1996, pp. 2212-2216
COMPARATIVE KINETIC ANALYSES OF INTERACTION OF INHIBITORS WITH RAUSCHER MURINE LEUKEMIA-VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE TRANSCRIPTASES
Authors: CHERRINGTON JM FULLER MD MULATO AS ALLEN SJW KUNDER SC USSERY MA LESNIKOWSKI Z SCHINAZI RF SOMMADOSSI JP CHEN MS
Citation: Jm. Cherrington et al., COMPARATIVE KINETIC ANALYSES OF INTERACTION OF INHIBITORS WITH RAUSCHER MURINE LEUKEMIA-VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE TRANSCRIPTASES, Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1270-1273
9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE THERAPY OF ESTABLISHED SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN INFANT RHESUS MACAQUES
Authors: VANROMPAY KKA CHERRINGTON JM MARTHAS ML BERARDI CJ MULATO AS SPINNER A TARARA RP CANFIELD DR TELM S BISCHOFBERGER N PEDERSEN NC
Citation: Kka. Vanrompay et al., 9-[2-(PHOSPHONOMETHOXY)PROPYL]ADENINE THERAPY OF ESTABLISHED SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN INFANT RHESUS MACAQUES, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2586-2591
HIV-1 VIRAL ISOLATES WITH REDUCED SENSITIVITY TO PMEA
Authors: CHERRINGTON JM MULATO AS FULLER MD CHEN MS
Citation: Jm. Cherrington et al., HIV-1 VIRAL ISOLATES WITH REDUCED SENSITIVITY TO PMEA, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 12-12
K65R MUTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENCODES CROSS-RESISTANCE TO 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE
Authors: GU ZX SALOMON H CHERRINGTON JM MULATO AS CHEN MS YARCHOAN R FOLI A SOGOCIO KM WAINBERG MA
Citation: Zx. Gu et al., K65R MUTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENCODES CROSS-RESISTANCE TO 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1888-1891
Risultati: 1-14 |